Written questions by Jones.

Innovation and Technology, what assessment she has made of the potential merits of animal-free tests such as the AcutoX for phasing out the LD50 test.

The strategy uses ‘baskets’ to group animal tests according to their readiness for replacement, based on maturity of potential alternative methods. These initial baskets will be refined in consultation with stakeholders, noting that two LD/LC50 tests are already in baskets 1 and 2 (botulinum potency and fish acute toxicity tests respectively) so are among the first targeted for phase-out. The Acutox test is a non-regulatory test and not yet validated for use in safety assessments. We will establish a new UK Centre for the Validation of Alternative Methods (UKCVAM) to accelerate alternative method validation and uptake for regulatory decision making.

Innovation and Technology, what assessment she has made of the potential implications for her policies on phasing out animal testing of the Federal Drug Agency's Roadmap to Reducing Animal Testing in Preclinical Safety Studies, published in April 2025.

I refer the hon. Member for Newport West and Islwyn to the answer that was provided on 15 May 2025 to Question UIN 51423.

Innovation and Technology, when her Department plans to publish the alternative methods to animal testing strategy.

The Labour Manifesto commits to “partner with scientists, industry, and civil society as we work towards the phasing out of animal testing”, which is a long-term goal.The government will publish a strategy to support the development, validation and uptake of alternative methods by the end of this year.

Innovation and Technology, if he will make an assessment of the potential implications for his policies of the proposed roadmap for the phasing out animal testing for chemicals being developed by the European Commission.

The Government is committed to supporting alternatives to animals in science and will publish a strategy to support their development, validation and adoption later this year. We have reviewed the European Commission's (EC) Life Sciences Strategy and engaged with the European Medicines Agency on accelerating the science-led adoption of alternatives for a range of uses of animals in science, including chemicals, medicines and cosmetics. Government officials regularly attend international meetings to collaborate on best practice and consider approaches to reducing reliance on animal testing, including attending European Commission workshops on the EC roadmap to phasing out animal testing for chemicals.

Innovation and Technology, whether she has had recent discussions with the Chancellor of the Exchequer on funding for the national semiconductor strategy.

Semiconductors have been confirmed by the UK government as one of six priority frontier technologies in the recently published Industrial Strategy Digital and Technologies sector plan. During the development of the Industrial Strategy, the Department met regularly with HM Treasury and the Department for Business and Trade to discuss how to best support the frontier technologies, including semiconductors.This led to several announcements including £19 million for a new UK Semiconductor Centre to coordinate the sector and act as a “front door” for international cooperation, £35 million towards a UK-wide skills programme to grow the talent pipeline, and £25 million for two new “Innovation and Knowledge Centres” that will enable researchers to work with industry to commercialise research in emerging semiconductor technologies.

Innovation and Technology, whether she has considered creating a dedicated photonics group within her Department.

Photonics is a major UK industry, generating £18.5 billion annually and employing over 84,800 people. It underpins quantum technologies, semiconductors, and telecoms, with government support through programmes like the National Quantum Technologies Programme and wider UKRI initiatives. The Fraunhofer Centre for Applied Photonics in Glasgow plays a leading role in research and commercialisation, particularly in tying together the quantum and photonics clusters. Government supports the UK's photonics capabilities through targeted interventions that support individual sector needs, fostering innovation and growth across emerging technology areas.

Innovation and Technology, what recent assessment she has made of the potential contribution of the photonics industry to economic (a) strategy and (b) growth.

Photonics is a major UK industry, generating £18.5 billion annually and employing over 84,800 people. It underpins quantum technologies, semiconductors, and telecoms, with government support through programmes like the National Quantum Technologies Programme and wider UKRI initiatives. The Fraunhofer Centre for Applied Photonics in Glasgow plays a leading role in research and commercialisation, particularly in tying together the quantum and photonics clusters. Government supports the UK's photonics capabilities through targeted interventions that support individual sector needs, fostering innovation and growth across emerging technology areas.

Innovation and Technology, what assessment she has made of the potential impact of the establishment of a National Centre for Photonics on technological development in the photonics industry.

Photonics is a major UK industry, generating £18.5 billion annually and employing over 84,800 people. It underpins quantum technologies, semiconductors, and telecoms, with government support through programmes like the National Quantum Technologies Programme and wider UKRI initiatives. The Fraunhofer Centre for Applied Photonics in Glasgow plays a leading role in research and commercialisation, particularly in tying together the quantum and photonics clusters. Government supports the UK's photonics capabilities through targeted interventions that support individual sector needs, fostering innovation and growth across emerging technology areas.

Innovation and Technology, what steps her Department is taking to support the development of a roadmap for the application of photonics to emerging technologies beyond telecommunications.

Photonics is a major UK industry, generating £18.5 billion annually and employing over 84,800 people. It underpins quantum technologies, semiconductors, and telecoms, with government support through programmes like the National Quantum Technologies Programme and wider UKRI initiatives. The Fraunhofer Centre for Applied Photonics in Glasgow plays a leading role in research and commercialisation, particularly in tying together the quantum and photonics clusters. Government supports the UK's photonics capabilities through targeted interventions that support individual sector needs, fostering innovation and growth across emerging technology areas.

Innovation and Technology, what steps she is taking to support the creation of new pilot lines for photonics.

The UK’s Modern Industrial Strategy recognises the opportunity to capitalise on our strength in photonics, chip design, and advanced technologies. To deliver this, DSIT is considering infrastructure needs as recommended by the Royal Academy of Engineering’s quantum infrastructure review. The UK already has strengths in photonics including Scotland’s photonics cluster, supported by centres like the James Watt Nanofabrication Centre and the Fraunhofer Centre for Applied Photonics. UK universities, such as Southampton and Cambridge, contribute to European photonics pilot lines with DSIT funding. The DSIT-funded Innovation and Knowledge Centre at Cornerstone focuses on commercial translation of silicon photonics research.

Innovation and Technology, what assessment she has made of the potential merits of facilitating the creation of a silicon photonics pilot line.

The UK’s Modern Industrial Strategy recognises the opportunity to capitalise on our strength in photonics, chip design, and advanced technologies. To deliver this, DSIT is considering infrastructure needs as recommended by the Royal Academy of Engineering’s quantum infrastructure review. The UK already has strengths in photonics including Scotland’s photonics cluster, supported by centres like the James Watt Nanofabrication Centre and the Fraunhofer Centre for Applied Photonics. UK universities, such as Southampton and Cambridge, contribute to European photonics pilot lines with DSIT funding. The DSIT-funded Innovation and Knowledge Centre at Cornerstone focuses on commercial translation of silicon photonics research.

Innovation and Technology, with reference to the Spending Review 2025, published on 11 June 2025, what proportion of the £22.6 billion increase to research and development funding by 2029-30 will be allocated to support the (a) development, (b) validation and (c) uptake of alternative methods to animal testing.

UK Research and Innovation (UKRI) invests to support research which can lead to alternatives, such as organ-on-a-chip, cell-based assays, functional genomics and computer modelling. These are categorised as basic research, so calculating funding for alternative methods specifically is not possible. Future investment will be determined by internal allocations of DSIT’s spending review settlement announced on 11.06.25. UKRI also invests £10 million annually in the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and is conducting a five-year review to guide future investment.The Government will publish a strategy to support non-animal alternatives later this year.

Innovation and Technology, with reference to the Spending Review 2025, published on 11 June 2025, what assessment he has made of the adequacy of funding for artificial Intelligence to replace the use of animals in medical research.

The Government is committed to non-animal alternatives and will publish a strategy to support their development, validation and adoption later this year. While it is not yet possible to replace all animal use, we support approaches that replace, reduce and refine animal use in research, including via artificial intelligence. The Prime Minister launched the AI Opportunities Action Plan in January to drive AI development and deployment. The Government co-funds seven Centres of Excellence for Regulatory Science and Innovation (CERSI), two focusing on AI which will support alternative method development. Internal allocations of DSIT’s spending review settlement will determine future investment.

Innovation and Technology, what assessment his Department has made of the potential merits of a Ministerial position dedicated to non-animal New-Approach Methodologies.

The Labour Manifesto commits to “partner with scientists, industry, and civil society as we work towards the phasing out of animal testing” and the Government will publish a strategy to support the development, validation and uptake of alternative methods later this year.As the Minister for Science, Research and Innovation Lord Vallance leads on this issue. He recognises this touches on a number of Departmental responsibilities and actively collaborates with fellow Ministers in relevant Departments to work together to support the delivery of important scientific research, including the development and implementation of alternative methods to animal testing.

Innovation and Technology, what his planned timeline is for phasing out the use of animal testing for regulatory and research purposes.

The Labour Manifesto includes a commitment to “partner with scientists, industry, and civil society as we work towards the phasing out of animal testing”, which is a long-term goal.The Government will publish a strategy to support the development, validation and uptake of alternative methods later this year, which will set out clear objectives and measurable milestones. Any work to phase out animal testing, including the use of dogs in regulatory scientific procedures, must be science-led and in lock step with partners including regulators, so we will not be setting interim targets or arbitrary timelines for reducing their use.

Innovation and Technology, what discussions he has held with stakeholders in the life sciences and technology sectors on the potential for artificial intelligence to support the uptake of non-animal New Approach Methodologies.

The Labour Manifesto includes a commitment to “partner with scientists, industry, and civil society as we work towards the phasing out of animal testing”. The Government will publish a strategy to support the development, validation and uptake of alternative methods later this year.Minister Vallance hosted a roundtable on 05.09.24 with industry representatives, including discussing the application of AI and officials have kept in regular contact with industry since then. The Government is also co-funding seven Centres of Excellence for Regulatory Science and Innovation (CERSI), two of which focus on AI which will support developing alternative methods.

Innovation and Technology, what steps his Department is taking to support the (a) development and (b) deployment of artificial intelligence to accelerate the transition away from the use of animals in scientific research and testing.

The Labour Manifesto commits to “partner with scientists, industry, and civil society as we work towards the phasing out of animal testing”. While it is not yet possible to replace all animal use, we support the development and application of approaches that replace, reduce and refine animal use in research (the 3Rs), including via artificial intelligence. The Prime Minister launched the AI Opportunities Action Plan in January which outlined 50 actions needed to drive up the development and deployment of AI.The Government will publish a strategy to support the development, validation and uptake of alternative methods later this year.

Innovation and Technology, what steps his Department is taking to ensure that the semiconductor skills package increases skills in science sectors.

The £4.75 million semiconductor skills package will increase the supply of skilled science and engineering workers. It includes school outreach in regional clusters, chip design courses for undergraduates, and a flagship semiconductor bursary scheme for 300 students starting Electronics and Electrical Engineering degrees, all of which will increase skill supply for the UK’s sector. This initiative will help key growth hubs like the South Wales Compound Semiconductor Cluster access the expertise needed to thrive and for the UK sector to achieve projected revenues of £16.7 billion by 2030.

Innovation and Technology, what assessment his Department has made of the potential implications for its policies of the US Food and Drug Administration's publication entitled Roadmap to Reducing Animal Testing in Preclinical Safety Studies, published on 10 April 2025.

It is not yet possible to replace all animal use due to the complexity of biological systems and regulatory requirements for their use. The Government has reviewed the FDA roadmap and is engaging with the MHRA on how to accelerate the science-led adoption of alternatives to the use of animals for drug development and testing. The Government will publish a strategy later this year that will support this ambition and accelerate the development, validation and uptake of alternative methods across the biosciences.

Innovation and Technology, what steps his Department is taking to help develop supply chains for (a) compound semiconductors and (b) other critical semiconductor materials.

This Government is supporting the development of supply chains for compound semiconductors and other critical semiconductor materials as part of our work to deliver the upcoming Industrial Strategy, which includes Digital and Technologies as a priority growth-driving sector. We recently secured a £250 million investment from one of the world’s largest manufacturers of semiconductors - Vishay Technologies – into the UK’s largest semiconductor facility as part of plans to develop large-scale compound semiconductor manufacturing in the UK, supported by the government’s Automotive Transformation Fund. Investments such as this will help develop UK supply chains in this high growth area of technology.